Carmat has secured conditional approval from the FDA to commence the second cohort of its EFS in the US with the Aeson artificial heart.

NEC Laboratories Europe and Data-Driven.AI are collaborating to advance medical diagnoses with the use of artificial intelligence (AI) and machine learning (ML).

Satio and Nanowear have entered into a partnership agreement aimed at progressing home-based diagnostic and therapeutic care.

Nexalin has received patent approval from the USPTO for its DIFS method for treating substance use disorders (SUD).

The FDA has approved the sale of Bruno Vision Care’s Deseyne contact lenses, which incorporate FusionTechnology, in the US market.

The University of Birmingham has secured £230,00 ($303,000) in funding from Cancer Research Horizons towards the development ...

Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...

Dutch diagnostics company Inbiome has secured the EU's In Vitro Diagnostic Regulation (IVDR) certification for its rapid ...

During a speech at the FDA, the HHS secretary accused staff of becoming "sock puppets" of the industry they regulate. Last week, Robert F Kennedy, Jr (RFK Jr) gave a speech at the US Food and Drug ...

Researchers from Weill Cornell Medicine (WCM) and New York Genome Center (NYGC), US, have identified an “accurate” and ...

The FDA has granted 510(k) clearance to Turbett Surgical's improved line of Instrument Pods, notably the TS1500, TS1200, and ...

Keensight Capital has axed plans to acquire British medical device manufacturer Niox Group in light of the “current ...